NasdaqGS - Nasdaq Real Time Price • USD
Kamada Ltd. (KMDA)
As of 10:40 AM EDT. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
142,519.00
142,519.00
129,339.00
103,642.00
133,246.00
Cost of Revenue
87,029.00
87,029.00
82,636.00
73,314.00
85,694.00
Gross Profit
55,490.00
55,490.00
46,703.00
30,328.00
47,552.00
Operating Expense
45,426.00
45,426.00
42,171.00
31,024.00
28,315.00
Operating Income
10,064.00
10,064.00
4,532.00
-696.00
19,237.00
Net Non Operating Interest Income Expense
-710.00
-710.00
-823.00
12.00
761.00
Other Income Expense
-925.00
-925.00
-5,968.00
-1,201.00
-1,433.00
Pretax Income
8,429.00
8,429.00
-2,259.00
-1,885.00
18,565.00
Tax Provision
145.00
145.00
62.00
345.00
1,425.00
Net Income Common Stockholders
8,284.00
8,284.00
-2,321.00
-2,230.00
17,140.00
Diluted NI Available to Com Stockholders
8,284.00
8,284.00
-2,321.00
-2,230.00
17,140.00
Basic EPS
0.17
0.17
-0.05
-0.05
0.39
Diluted EPS
0.15
0.15
-0.05
-0.05
0.38
Basic Average Shares
48,830.48
48,830.48
44,815.25
44,771.77
43,948.72
Diluted Average Shares
53,675.51
53,675.51
44,856.58
44,901.94
45,105.26
Total Operating Income as Reported
10,064.00
10,064.00
4,532.00
-696.00
19,237.00
Total Expenses
132,455.00
132,455.00
124,807.00
104,338.00
114,009.00
Net Income from Continuing & Discontinued Operation
8,284.00
8,284.00
-2,321.00
-2,230.00
17,140.00
Normalized Income
8,229.95
8,229.95
-2,550.46
-2,070.61
18,462.66
Interest Income
588.00
588.00
91.00
295.00
1,027.00
Interest Expense
1,298.00
1,298.00
914.00
283.00
266.00
Net Interest Income
-710.00
-710.00
-823.00
12.00
761.00
EBIT
9,727.00
9,727.00
-1,345.00
-1,602.00
18,831.00
EBITDA
22,441.00
22,441.00
10,810.00
4,007.00
23,728.00
Reconciled Cost of Revenue
77,440.00
77,440.00
73,510.00
69,068.00
81,723.00
Reconciled Depreciation
12,714.00
12,714.00
12,155.00
5,609.00
4,897.00
Net Income from Continuing Operation Net Minority Interest
8,284.00
8,284.00
-2,321.00
-2,230.00
17,140.00
Total Unusual Items Excluding Goodwill
55.00
55.00
298.00
-207.00
-1,433.00
Total Unusual Items
55.00
55.00
298.00
-207.00
-1,433.00
Normalized EBITDA
22,386.00
22,386.00
10,512.00
4,214.00
25,161.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
0.95
0.95
68.54
-47.61
-110.34
12/31/2020 - 5/31/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LFCR Lifecore Biomedical, Inc.
6.31
-2.17%
EVO Evotec SE
5.05
-35.17%
AMRX Amneal Pharmaceuticals, Inc.
5.77
+6.85%
TARO Taro Pharmaceutical Industries Ltd.
42.20
-0.07%
RDHL RedHill Biopharma Ltd.
0.4221
-1.59%
HCM HUTCHMED (China) Limited
18.38
+0.71%
INCR InterCure Ltd.
2.7005
+4.67%
PBH Prestige Consumer Healthcare Inc.
70.55
-0.94%
RDY Dr. Reddy's Laboratories Limited
71.18
-0.44%
INDV Indivior PLC
18.94
+1.66%